The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
IL-17 Enhances the Net Angiogenic Activity and In Vivo Growth of Human Non-Small Cell Lung Cancer in SCID Mice through Promoting CXCR-2-Dependent Angiogenesis
Open accessAbstract
In this study, we examined the biological action of IL-17 on human non-small cell lung cancer (NSCLC). Although IL-17 had no direct effect on the in vitro growth rate of NSCLC, IL-17 selectively augmented the secretion of an array of angiogenic CXC chemokines, including CXCL1, CXCL5, CXCL6, and CXCL8 but not angiostatic chemokines, by three different NSCLC lines. Endothelial cell chemotactic activity (as a measure of net angiogenic potential) was increased in response to conditioned medium from NSCLC stimulated with IL-17 compared with those from unstimulated NSCLC. Enhanced chemotactic activity was suppressed by neutralizing mAb(s) to CXCL1, CXCL5, and CXCL8 or to CXCR-2 but not to vascular endothelial growth factor-A. Transfection with IL-17 into NSCLC had no effect on the in vitro growth, whereas IL-17 transfectants grew more rapidly compared with controls when transplanted in SCID mice. This IL-17-elicited enhancement of NSCLC growth was associated with increased tumor vascularity. Moreover, treatment with anti-mouse CXCR-2-neutralizing Ab significantly attenuated the growth of both neomycin phosphotransferase gene-transfected and IL-17-transfected NSCLC tumors in SCID mice. A potential role for IL-17 in modulation of the human NSCLC phenotype was supported by the findings that, in primary NSCLC tissues, IL-17 expression was frequently detected in accumulating and infiltrating inflammatory cells and that high levels of IL-17 expression were associated with increased tumor vascularity. These results demonstrate that IL-17 increases the net angiogenic activity and in vivo growth of NSCLC via promoting CXCR-2-dependent angiogenesis and suggest that targeting CXCR-2 signaling may be a novel promising strategy to treat patients with NSCLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Oonakahara, K.-I., Matsuyama, W., Higashimoto, I., Kawabata, M., Arimura, K., & Osame, M. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0340oc · Cited by 82
RetractedPatterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
Interleukin-8 as a macrophage-derived mediator of angiogenesis
Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., & Strieter, R. M. (1992) · Science · doi:10.1126/science.1281554 · Cited by 2,135
Induction of angiogenesis during the transition from hyperplasia to neoplasia
Folkman, J., Watson, K., Ingber, D., & Hanahan, D. (1989) · Nature · doi:10.1038/339058a0 · Cited by 1,879
Holmgren, L., O'Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,878
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5703 · Cited by 1,696
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2593 · Cited by 1,526
Thomson, A. W. (1994) · Cited by 1,116
Human IL-17: a novel cytokine derived from T cells
Yao, Z., Painter, S. L., Fanslow, W. C., Ulrich, D., Macduff, B. M., Spriggs, M. K., & Armitage, R. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.12.5483 · Cited by 1,021
Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A.-M., Painter, S. L., Comeau, M. R., Cohen, J. I., & Spriggs, M. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90070-5 · Cited by 994
Jovanović, D., Battista, J. A. D., Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F., & Martel‐Pelletier, J. (1998) · PubMed · Cited by 973
IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines
Molet, S., Hamid, Q., Davoineb, F., Nutku, E., Tahaa, R., Pagé, N., Olivenstein, R., Elias, J., & Chakir, J. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.117929 · Cited by 953
Jovanovic, D. V., Di Battista, J. A., Martel-Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F., & Pelletier, J.-P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3513 · Cited by 867
Interleukin-17 promotes angiogenesis and tumor growth
Numasaki, M. (2003) · Blood · doi:10.1182/blood-2002-05-1461 · Cited by 834
Self-citationRouvier, E., Luciani, M. F., Mattéi, M. G., Denizot, F., & Golstein, P. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5445 · Cited by 775
Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.
Angiolillo, A. L., Sgadari, C., Taub, D. D., Liao, F., Farber, J. M., Maheshwari, S., Kleinman, H. K., Reaman, G. H., & Tosato, G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.155 · Cited by 705
Microbial lipopeptides induce the production of IL-17 in Th cells
Infante-Duarte, C., Horton, H. F., Byrne, M. C., & Kamradt, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6107 · Cited by 586 · cited 1×
“In contrast, physiological regulation of IL-17 production by CD4 T cells has not been fully elucidated (62, 63).”
BackgroundAddison, C. L., Daniel, T. O., Burdick, M. D., Liu, H., Ehlert, J. E., Xue, Y. Y., Buechi, L., Walz, A., Richmond, A., & Strieter, R. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.5269 · Cited by 575
Teunissen, M. B. M., Bos, J. D., Koomen, C. W., de Waal Malefyt, R., & Wierenga, E. A. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00347.x · Cited by 570
Hymowitz, S. G., Filvaroff, E. H., Yin, J., Lee, J., Cai, L., Risser, P., Maruoka, M., Mao, W., Foster, J., Kelley, R. F., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.19.5332 · Cited by 548
IL-17 Is Produced by Some Proinflammatory Th1/Th0 Cells But Not by Th2 Cells
Aarvak, T., Chabaud, M., Miossec, P., & Natvig, J. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1246 · Cited by 410
Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.
Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Glass, M., Burdick, M. D., & Strieter, R. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118734 · Cited by 403
Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.
Smith, D. R., Polverini, P. J., Kunkel, S. L., Orringer, M. B., Whyte, R. I., Burdick, M. D., Wilke, C. A., & Strieter, R. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1409 · Cited by 373
Walz, A., Burgener, R., Car, B., Baggiolini, M., Kunkel, S. L., & Strieter, R. M. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1355 · Cited by 353
Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Morris, S. B., Burdick, M. D., Glass, M. C., Taub, D. T., Iannettoni, M. D., Whyte, R. I., & Strieter, R. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.981 · Cited by 353
Starnes, T., Robertson, M. J., Sledge, G., Kelich, S., Nakshatri, H., Broxmeyer, H. E., & Hromas, R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4137 · Cited by 349
Chabaud, M., Lubberts, E., Joosten, L., van den Berg, W., & Miossec, P. (2001) · Arthritis Research & Therapy · doi:10.1186/ar294 · Cited by 333
Coughlin, C. M., Salhany, K. E., Gee, M. S., LaTemple, D. C., Kotenko, S., Ma, X., Gri, G., Wysocka, M., Kim, J. E., Liu, L., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80585-3 · Cited by 324
Fontanini, G., Vignati, S., Boldrini, L., Chinè, S., Silvestri, V., Lucchi, M., Mussi, A., Angeletti, C. A., & Bevilacqua, G. (1997) · PubMed · Cited by 306
Depletion of CXCR2 Inhibits Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer
Keane, M. P., Belperio, J. A., Xue, Y. Y., Burdick, M. D., & Strieter, R. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2853 · Cited by 305
Antonysamy, M. A., Fanslow, W. C., Fu, F., Li, W., Qian, S., Troutt, A. B., & Thomson, A. W. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.577 · Cited by 293
Rathanaswami, P., Hachicha, M., Sadick, M., Schall, T. J., & McColl, S. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53395-0 · Cited by 291
Tartour, É., Fossiez, F., Joyeux, I., Galinha, A., Gey, A., Claret, E. J., Sastre‐Garau, X., Couturier, J., Mosseri, V., Vives, V., et al. (1999) · PubMed · Cited by 290
MOLECULAR CHARACTERIZATION OF THE HUMAN INTERLEUKIN (Il)-17 RECEPTOR
Yao, Z., Spriggs, M. K., Derry, J. M. J., Strockbine, L., Park, L. S., VandenBos, T., Zappone, J., Painter, S. L., & Armitage, R. J. (1997) · Cytokine · doi:10.1006/cyto.1997.0240 · Cited by 280
Kaplan, G., Luster, A. D., Hancock, G., & Cohn, Z. A. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.4.1098 · Cited by 266
Arenberg, D. A., Keane, M. P., DiGiovine, B., Kunkel, S. L., Morris, S. B., Xue, Y. Y., Burdick, M. D., Glass, M. C., Iannettoni, M. D., & Strieter, R. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3145 · Cited by 259
Role of C-X-C chemokines as regulators of angiogenesis in lung cancer
Strieter, R. M., Polverini, P. J., Arenberg, D. A., Walz, A., Opdenakker, G., Van Damme, J., & Kunkel, S. L. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.5.752 · Cited by 250
Mig, the Monokine Induced By Interferon-γ, Promotes Tumor Necrosis In Vivo
Sgadari, C., Farber, J. M., Angiolillo, A. L., Liao, F., Teruya-Feldstein, J., Burd, P. R., Yao, L., Gupta, G., Kanegane, C., & Tosato, G. (1997) · Blood · doi:10.1182/blood.v89.8.2635 · Cited by 246
Steiner, G. E., Newman, M. E., Paikl, D., Stix, U., Memaran‐Dagda, N., Lee, C., & Marberger, M. J. (2003) · The Prostate · doi:10.1002/pros.10238 · Cited by 238
Cytokine networks in solid human tumors: regulation of angiogenesis
Leek, R. D., Harris, A. L., & Lewis, C. E. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.56.4.423 · Cited by 207
Hashimoto, W., Osaki, T., Okamura, H., Robbins, P. D., Kurimoto, M., Nagata, S., Lotze, M. T., & Tahara, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.583 · Cited by 196
Self-citationLoukinova, E., Dong, G., Enamorado-Ayalya, I., Thomas, G. R., Chen, Z., Schreiber, H., & Van Waes, C. (2000) · Oncogene · doi:10.1038/sj.onc.1203687 · Cited by 172
Expression of angiopoietins and its clinical significance in non-small cell lung cancer.
Tanaka, F., Ishikawa, S., Yanagihara, K., Miyahara, R., Kawano, Y., Li, M., Otake, Y., & Wada, H. (2002) · PubMed · Cited by 161
Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells
Takahashi, H., Numasaki, M., Lotze, M. T., & Sasaki, H. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.11.012 · Cited by 158
Self-citationThe role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer
Arenberg, D. A., Polverini, P. J., Kunkel, S. L., Shanafelt, A., Hesselgesser, J., Horuk, R., & Strieter, R. M. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.5.554 · Cited by 158
Expression of IL-17 mRNA in Ovarian Cancer
Kato, T., Furumoto, H., Ogura, T., Onishi, Y., Irahara, M., Yamano, S., Kamada, M., & Aono, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4618 · Cited by 152
Maertzdorf, J., Osterhaus, A. D. M. E., & Verjans, G. M. G. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5897 · Cited by 138
Numasaki, M., Lotze, M. T., & Sasaki, H. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.01.014 · Cited by 133
Self-citationCirée, A., Michel, L., Camilleri‐Broët, S., Jean‐Louis, F., Oster, M., Flageul, B., Senet, P., Fossiez, F., Fridman, W. H., Bachelez, H., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20373 · Cited by 124
Schnyder‐Candrian, S., Strieter, R. M., Kunkel, S. L., & Walz, A. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.6.929 · Cited by 102
Expression in lung carcinomas of platelet-derived growth factor and its receptors.
Kawai, T., Hiroi, S., & Torikata, C. (1997) · PubMed · Cited by 97
IL-2 up-regulates but IFN-gamma suppresses IL-8 expression in human monocytes.
Gusella, G. L., Musso, T., Bosco, M. C., Espinoza‐Delgado, I., Matsushima, K., & Varesio, L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2725 · Cited by 94
Gattass, C. R., King, L. B., Luster, A. D., & Ashwell, J. D. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1373 · Cited by 81
Ogawa, T., Takayama, K., Takakura, N., Kitano, S., & Ueno, H. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700478 · Cited by 76
Hsieh, E., Shepherd, F. A., & Tsao, M. (2000) · Lung Cancer · doi:10.1016/s0169-5002(00)00116-1 · Cited by 66
Takabatake, M., Hishinuma, T., Suzuki, N., Chiba, S., Tsukamoto, H., Nakamura, H. K., Saga, T., Tomioka, Y., Kurose, A., Sawai, T., et al. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2002.0381 · Cited by 53
Self-citationVariability Among Human Umbilical Vein Endothelial Cultures
Watson, C. A., Camera-Benson, L., Palmer-Crocker, R., & Pober, J. S. (1995) · Science · doi:10.1126/science.7716553 · Cited by 53
Tsao, M., Yang, Y., Marcus, A., Liu, G., & Mou, L.-J. (2001) · Human Pathology · doi:10.1053/hupa.2001.21133 · Cited by 52
Nyhlén, K., Linden, M., Andersson, R. G. G., et al. (2000) · Cytokine · doi:10.1006/cyto.1999.0557 · Cited by 51
Numasaki, M., Takahashi, H., Tomioka, Y., & Sasaki, H. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.06.010 · Cited by 35
Self-citationNumasaki, M., Tomioka, Y., Takahashi, H., & Sasaki, H. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.07.002 · Cited by 31
Self-citationAntonysamy, M. A., & Numasaki, M. (2003) · Elsevier eBooks · doi:10.1016/b978-012689663-3/50024-7 · Cited by 8
Self-citation
Cited by
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940
Tumors as Organs: Complex Tissues that Interface with the Entire Organism
Egeblad, M., Nakasone, E. S., & Werb, Z. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.05.012 · Cited by 1,234
Tesmer, L. A., Lundy, S. K., Sarkar, S., & Fox, D. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00628.x · Cited by 1,102
Tumor-specific Th17-polarized cells eradicate large established melanoma
Muranski, P., Boni, A., Antony, P. A., Cassard, L., Irvine, K. R., Kaiser, A., Paulos, C. M., Palmer, D. C., Touloukian, C. E., Ptak, K., et al. (2008) · Blood · doi:10.1182/blood-2007-11-120998 · Cited by 845
IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
Wang, L., Yi, T., Kortylewski, M., Pardoll, D. M., Zeng, D., & Yu, H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090207 · Cited by 842
Metadata
- Authors
- Numasaki, M., Watanabe, M., Suzuki, T., Takahashi, H., Nakamura, A., McAllister, F., Hishinuma, T., Goto, J., Lotze, M. T., Kolls, J. K., & Sasaki, H.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-11-01
- Volume
- 175
- Issue
- 9
- Pages
- 6177-6189
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1935309503
- Cited by
- 416
- References
- 64
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.